NURS6403 builds the FNP's competency in reproductive health — an area of primary care that spans contraception counseling, preconception health optimization, pregnancy management, gynecological condition assessment, STI prevention and treatment, and menopausal transition care. For many patients, particularly in underserved communities, the FNP is the primary (and sometimes only) provider of reproductive health services, making this course essential to the FNP's population health impact.
Reproductive health domains across the lifespan
| Domain | Key Clinical Content | FNP Role |
|---|---|---|
| Contraception | LARC (IUDs, implants), hormonal methods (OCs, patch, ring, injection), barrier methods, emergency contraception, sterilization | Counseling using shared decision-making, US MEC eligibility criteria, insertion/removal of LARC devices (with training) |
| Preconception care | Folic acid supplementation, chronic disease optimization, medication teratogenicity review, genetic screening, lifestyle counseling | Proactive identification and counseling of reproductive-age patients planning pregnancy |
| Prenatal care | Initial prenatal visit, trimester-specific screening, routine labs, fetal assessment, common pregnancy complications | Managing uncomplicated pregnancies and co-managing with OB for high-risk; recognizing when to refer |
| Gynecological conditions | Abnormal uterine bleeding, PCOS, endometriosis, cervical cancer screening, breast health, pelvic floor disorders | Diagnosis, initial management, and appropriate specialist referral |
| Menopause | Vasomotor symptoms, genitourinary syndrome of menopause, hormone therapy risks/benefits, osteoporosis prevention | Symptom management, HRT shared decision-making using NAMS/AMS guidelines, bone density screening |
What NURS6403 covers
Contraception counseling is a core FNP competency, and NURS6403 teaches the tiered-effectiveness approach recommended by ACOG — presenting the most effective methods first (LARC: IUDs and implants with <1% failure rate) while respecting patient autonomy and preferences. The US Medical Eligibility Criteria (US MEC) guides safe method selection based on medical conditions — the FNP must know which conditions are absolute contraindications (Category 4) versus relative contraindications (Category 3) for each method. Common clinical scenarios include contraception for patients with migraines with aura (estrogen contraindicated), hypertension, obesity, breastfeeding, and history of VTE.
STI screening and treatment follows CDC Sexually Transmitted Infections Treatment Guidelines. NURS6403 covers screening recommendations (chlamydia/gonorrhea annually for sexually active women under 25 and those with risk factors; HIV screening for all patients 13–64; syphilis, hepatitis B/C based on risk), specimen collection, result interpretation, treatment protocols, partner notification and expedited partner therapy (where state law permits), and reporting requirements. The FNP must be comfortable discussing sexual history using the 5 P's framework (Partners, Practices, Protection, Past STIs, Prevention of pregnancy) in a nonjudgmental, culturally sensitive manner.
Working on a reproductive health case study, contraception counseling analysis, or prenatal care paper?
Our FNP writers develop reproductive health papers with the clinical sophistication Capella's NURS6403 rubric requires.
Key topics in NURS6403
- Contraception: LARC, hormonal, barrier methods; US MEC eligibility; shared decision-making
- Preconception health: folic acid, chronic disease optimization, teratogen review, genetic counseling referral
- Prenatal care: initial visit, routine labs, trimester screening, common complications, referral criteria
- STI screening and treatment: CDC guidelines, 5 P's sexual history, partner notification, expedited partner therapy
- Cervical cancer screening: Pap smear and HPV co-testing guidelines (ASCCP), abnormal result management
- Abnormal uterine bleeding: evaluation workup, hormonal and non-hormonal management, referral indications
- PCOS: diagnostic criteria (Rotterdam), metabolic implications, management across reproductive goals
- Menopause: vasomotor symptoms, GSM, hormone therapy, non-hormonal alternatives, bone health
US Medical Eligibility Criteria (US MEC) for contraceptive use — key categories
- Category 1: no restriction — method can be used in any circumstance
- Category 2: advantages generally outweigh risks — method can generally be used
- Category 3: risks usually outweigh advantages — method not usually recommended unless other methods unavailable
- Category 4: unacceptable health risk — method should not be used
- Example: combined hormonal contraceptives are Category 4 for migraine with aura (stroke risk), hypertension ≥160/100, current VTE, <21 days postpartum, and breast cancer
Get Help With NURS6403
Contraception analyses, prenatal care papers, STI management case studies. FNP reproductive health coursework done right.
Place Your OrderView All ServicesRelated courses
Frequently asked questions
Yes, FNPs can provide prenatal care for uncomplicated pregnancies within their scope of practice, though this varies by state and practice setting. In many primary care and community health settings, FNPs manage routine prenatal care — initial prenatal visit, routine screenings, anticipatory guidance, and well-pregnancy management — with referral to OB/GYN or CNM for delivery and high-risk complications. In rural and underserved areas, FNPs are often the primary prenatal care provider. NURS6403 builds competency in managing normal pregnancy and recognizing conditions requiring referral: preeclampsia, gestational diabetes, placental abnormalities, preterm labor signs, and fetal growth concerns.
The USPSTF and ASCCP recommend: for ages 21–29, Pap smear alone every 3 years (HPV testing not recommended under 25 due to high transient infection rates); for ages 30–65, either Pap smear alone every 3 years, HPV testing alone every 5 years, or Pap/HPV co-testing every 5 years. Screening stops at age 65 with adequate prior screening and no history of CIN2+. For abnormal results, the ASCCP risk-based management guidelines use individualized risk calculators rather than a one-size-fits-all algorithm. The FNP must know both screening recommendations and management of abnormal results, including when to refer for colposcopy.
GSM (formerly called vulvovaginal atrophy) describes the constellation of genital, urinary, and sexual symptoms caused by estrogen decline during menopause: vaginal dryness, burning, irritation, dyspareunia, urinary urgency, frequency, recurrent UTIs, and sexual dysfunction. Unlike vasomotor symptoms which often improve over time, GSM is progressive and worsens without treatment. First-line treatment is vaginal moisturizers and lubricants; prescription options include low-dose vaginal estrogen (cream, tablet, ring), ospemifene (oral SERM), and prasterone (intravaginal DHEA). Low-dose vaginal estrogen is safe even in many patients for whom systemic HRT is contraindicated.
The 5 P's is a CDC-recommended framework for comprehensive sexual history: Partners (gender of partners, number of partners), Practices (types of sexual contact — vaginal, anal, oral), Protection from STIs (condom use, PrEP), Past STIs (previous diagnoses and treatment), and Prevention of pregnancy (current contraception use and satisfaction). The framework ensures complete risk assessment while providing a structured, nonjudgmental approach. NURS6403 emphasizes that sexual history is a routine part of primary care assessment, not a special topic reserved for symptomatic patients — and that inclusive, non-heteronormative language makes patients more likely to disclose accurate information.